他汀类药物在冠心病中应用的再认识
To Reevaluate the Application of Statins in Coronary Heart Disease (CHD)
摘要
流行病学显示近年来随着人们生活水平提高,生活方式及饮食习惯改变,老龄化人口增多,致冠心病危险因素的增加,尤其是脂质代谢紊乱,使冠状动脉粥样硬化性心脏病(简称冠心病CHD)的发病率、死亡率正在持续升高.
出处
《中国临床医学》
2004年第2期267-269,共3页
Chinese Journal of Clinical Medicine
参考文献16
-
1Brown MS. Goldstein JL. A receptor - mediated pathway for cholesterol homeostasis. Science, 1986, 232 :34-47. 被引量:1
-
2The long - Term Intervention with pravastatin in Ischaemic Disease (LIPID) study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1 被引量:2
-
3Pedersen TR, Kjekshus J. Pyorala K, et al. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4s). Am J Cardiol, 1998, 81:333-735. 被引量:2
-
4O'Driscoll G, Green, Taylor RR, et al. Simvastatin an HMG- Co - enzyme A reductase inhibitor improves endothelial function within 1 month. Circulation, 1997, 95:1126-1131. 被引量:2
-
5Vasa M, Fichtlsscher S, et al. Increase in circulating endotheliap progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation, 2001, 103: 2885 - 2890. 被引量:2
-
6Mueck AO, seeger H, et al. further evidence for direct vascular actions of statins: effect on endothelial nitric oxide synthase and adhesion molecules. Exp Clin Endocrinol Diabetes, 2001, 109:181-183. 被引量:2
-
7Crisby M, Mordin - Fredriksson G, Shah PK, et al. Pravastatin Treatment Increases Collagen Coutent and Decrease Lipid content, Inflammation, Metallo- proteinases, and Cell Death in Human Carotid Plaques: Implication for Plaque Stabilization.Circulation, 2 被引量:2
-
8Wassmann S, Laufs U. Inhibition of gerang of geranylgeranylation reduces angiotensin Ⅱ- mediated free radical production in vascular smooth muscle cells: involvment of angiotensin AT,receptor expression and Racl GTPase. Mol Pharmacol, 2001,59:646~654. 被引量:2
-
9Porter KE, Naik J, Turner NA, et al. Simvastatin inhibits human suphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration. Vasc Surg,2002, 36(1) :150-157. 被引量:2
-
10Pasterkamp G, Schoneveld AH, Vander Wal AC et al. Inflammation of the atherosclerotic cap and shoulder of the plaque is a common and locally observed feature in unruptured plaques of femoral and coronary ateries. Arterioscler Throm Vasc Biol,1999, 19:54~ 被引量:1
二级参考文献15
-
1Schonbeck U, Sukhova GK, Shimizu K, et al. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Nail Acad Sci USA, 2000, 97: 7458-7463. 被引量:1
-
2Lutgens E, Cleutjens KBJM, Heeneman S, et al. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc Nail Aced Sci. USA, 2000, 97: 7464-7469. 被引量:1
-
3Kai H,Ikeda H, Yasukawa H, et al. Perpherial blood levels of matrix metalloproteinase-2 and 9 are evelated In patients with acute coronary sndrome. J Am Coll Cardiol , 1998,32:368-372. 被引量:1
-
4Taku T, Toshio H, Hatsuyo K, et al. Cerivastatin, a HMG-CoA Reductase Inhibitor, Improves Endothelial Function In Elderly Diabetics winthin 3 days. Circulation, 2001,104:376-379. 被引量:1
-
5Ross R. Atherosclerosis-An inflammatory disease. N Eng J Med, 1999,340: 115-126. 被引量:1
-
6Goran K Hansson. Immune Mechanism In Atherosclerosis Arteroscler Thromb Vasc Biol . 2001,21:1876-1890. 被引量:1
-
7Koefig W. Inflammation and coronary heart disease:an overview Cardiol Rev, 2001,9:31-35. 被引量:1
-
8Mach F, Schonbeck U, Bonnefoy JY, et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation, 1997,96:396-399. 被引量:1
-
9Brown DL, Hibbs MS, Kearney M, et al. Identification 92 kDa gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation , 1995, 91: 2125-2131. 被引量:1
-
10Chalmers J, WHO-ISH Hypertension Guidelines Committee. 1999 World Health Organization-International Society of Hypertension Guidelines for Management of Hypertension. J Hypertens, 1999,17:151-183. 被引量:1
共引文献100
-
1林英忠,黄从新,王风,刘伶,徐广马.不同剂量普伐他汀对急性冠脉综合征血清胆固醇及高敏C反应蛋白金属蛋白酶-9的影响[J].中国医学文摘(老年医学),2007(3):161-165.
-
2赵继先,刘继军,袁良俊,聂炜娟.阿托伐他汀的早期干预治疗对急性冠状动脉综合征患者血清高敏C反应蛋白水平的影响[J].中国老年保健医学,2007,5(3):56-58.
-
3曹明.他汀类调脂药的临床应用[J].河北医药,2004,26(6):509-510. 被引量:7
-
4高智耀,刘继保,李伟杰,李亚军,韩建仑.阿托伐他汀在急性冠状动脉综合征患者早期应用的疗效分析[J].中国心血管杂志,2004,9(4):271-274. 被引量:2
-
5张素华,赵维江,曹治宸,黄建敏,潘丽萍.阿托伐他汀对急性冠状动脉综合征患者血清MMP-9及TIMP-1水平的影响[J].临床心血管病杂志,2004,20(9):534-536. 被引量:2
-
6秦晋梅,李建军.他汀类药物的抗炎作用[J].中国动脉硬化杂志,2004,12(3):363-366. 被引量:42
-
7高建秋,王爱华,任素文.他汀类药物作用的应用评价[J].中国医刊,2004,39(8):46-48. 被引量:11
-
8曾武涛,冷秀玉,王礼春,廖新学,马虹.早期调脂干预对急性心肌梗死患者炎症因子的影响[J].中国心血管杂志,2004,9(5):333-336. 被引量:2
-
9张发成,白玉云,李海鹰,高金凤,石翠霞.辛伐他汀对2型糖尿病患者一氧化氮和内皮素及C反应蛋白的影响[J].医师进修杂志,2004,27(11):25-27. 被引量:2
-
10白玉云,杨少清,张发成,李月惠,王秀芝.辛伐他汀对非高脂血症2型糖尿病患者一氧化氮和C反应蛋白的影响[J].临床荟萃,2004,19(23):1328-1330.
-
1郑华.老年人急性阑尾炎36例诊治体会[J].医学理论与实践,2011,24(10):1162-1163. 被引量:1
-
2陈卫丹,宋沈超,钟蜀华,石作宏.贵阳市2005-2012年肺结核疫情流行病学分析[J].贵州医药,2014,38(1):58-61. 被引量:7
-
3刘剑梅,韦美娥,唐志敏.社区护理干预对肺结核患者遵医行为的影响[J].医学文选,2002,21(6):946-946.
-
4刘莹.纤支镜检查在不典型肺结核诊断中的作用[J].中原医刊,2001,28(7):36-36.
-
5孙玲,窦红宇.对社区糖尿病患者综合干预的体会[J].中国初级卫生保健,2010,24(5):27-27. 被引量:2
-
6依光明.自测血压有3点好处[J].医药前沿,2012(21):67-67.
-
7李正华.28例老年人急性阑尾炎的诊治体会[J].医学理论与实践,2003,16(10):1158-1159.
-
8曹志云.老年肺结核并发下呼吸道感染36例临床分析[J].齐齐哈尔医学院学报,2002,23(8):874-874. 被引量:2
-
9侯森.老年急性阑尾炎47例临床分析[J].临床合理用药杂志,2009,2(20):83-83. 被引量:15
-
10牛晨霞,马建军.老年肺结核误诊原因浅析[J].临床误诊误治,2004,17(6):404-405. 被引量:5